Treace Medical Concepts, Inc. (TMCI)

♥ 346 Thanks from members

Treace Medical Concepts, Inc. (TMCI) demonstrated disciplined cash management and narrower net losses in Q2 2026 despite a slight 4% year-over-year revenue decline, prompting an increased full-year outlook and positive analyst price target adjustments.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

Microchip Technology Incorporated (MCHP)

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)

NASDAQ

AbCellera Biologics Inc. - Common Shares (ABCL)

Entity & Market Metadata

Sector: Healthcare Industry: Medical Devices & Equipment Founder: John T. Treace Leadership: John T. Treace (CEO) Leadership: Mark Hair (CFO) Holder: Treace Family Holder: BlackRock, Inc. Holder: The Vanguard Group Lapidus Bunionsplasty System Lapiplasty 3D System Adductoplasty System #TMCI #Treace Medical Concepts #Lapiplasty #bunion surgery device #NASDAQ TMCI